innovation for industry
Article | Micro-nanoelectronics
A unique interface between patients and the medical industry
Hub4aim has an unique proposal to manage the preindustrial
phase from the proof of concept to regulatory marking.
The startup Remedee Labs has designed the first endorphin stimulator for individual use, with the aim of providing an answer to patients' chronic pain.
Clinatec has been trying to effectively determine the best location in the brain for its WIMAGINE® implant, which measures the brain activity of tetraplegic patients.
The Clinatec endowment fund has earned the support of several patrons, including the Covea mutual insurance company, since 2020.
The problem with implantable medical monitoring devices for organs like the eye, brain, or heart, is that the power sources are often larger than the actual sensors.
Together, GTP Nano and the CEA have set the ambitious goal of covering the entire nanodrug value chain from lab to manufacturing plant to offer pharmaceutical companies full process development, GMP batch production, and aseptic fill and finish services.
Nano-biotechnology PlatformClinatec Platform
Connected Health ＆ WellnessAgriculture, Food Industry ＆ Environment
Smart Medical Technologies
See all demos
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.